How Should You Respond to FDA 483 Observations?

Author(s)Mahboubeh Lotfinia, R.D. McDowall

Is FDA getting tired of writing warning letters? A new draft guidance shows how companies should respond to Form 483 observations.

In March, the Agency published a draft guidance on Responding to FDA Form 483 Observations.¹ We will discuss it from a laboratory perspective, covering: